# Utility Of Citogenex Administration In Patients With Colon-Rectal Cancer

> **NCT01477866** · NA · SUSPENDED · sponsor: **University of Palermo** · enrollment: 250 (estimated)

## Conditions studied

- Colonic Neoplasms

## Interventions

- **DIETARY_SUPPLEMENT:** citogenex
- **OTHER:** conventional therapy

## Key facts

- **NCT ID:** NCT01477866
- **Lead sponsor:** University of Palermo
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 250 (ESTIMATED)
- **Why stopped:** the study has never started
- **Last updated:** 2017-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01477866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01477866, "Utility Of Citogenex Administration In Patients With Colon-Rectal Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01477866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*